Rimonabant

Rimonabant (also known as Acomplia, Bethin, Monaslim, Remonabent, Riobant, Slimona, Rimoslim, and Zimulti, Riomont) is an anorectic anti-obesity drug. Obesity contributes to heart disease, stroke, cancer, type II diabetes, and likely dozens of other diseases. A drug that reduces the incidence of obesity could substantially improve the long term health outlook for hundreds of millions of people.

Rimonabant is a novel medication used for the treatment of obesity and a number of other conditions as prescribed by your doctor. The drug works by blocking a specific brain receptor that impacts every person’s body weight and regulates the metabolism of glucose and lipids. According to a number of studies about a third of all people taking this medicine lost one tenth of their total body weight and were able to maintain the progress for two years, which is a very good result for a weight loss pill.

According to the manufacturing company Sanofi-Aventis this medicine can also prevent the risk of developing a cardiovascular disease and aid people in smoking cessation. This drug has been demonstrated to be most efficient for patients with large waist circumference – 88 and 102 centimeters in females and males respectively. Rimonabant is generally well tolerated with the most common side the effects being nausea and vomiting. Rimonabant should be combined with a very healthy diet and lifestyle. You can ask your doctor for recommendations on eating more healthily in order to achieve maximum effect. Rimonabant has been reported to cause suicidal thoughts in some patients taking it.